IntraOp Medical Corporation and the University of Verona in Italy announced today the enrollment of the first patient in the PancFORT Trial: A phase II study of primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma.
Read More
Media Inquiry
John McKinley
jmckinley@intraop.com
+1 408.636.1020 x122
Mail to:
570 Del Rey Avenue
Sunnyvale, CA 94085